aldosterone has been researched along with quinapril in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 8 (44.44) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Elsner, D; Kromer, EP; Riegger, GA | 1 |
| Bailey, RR; Begg, EJ; Frank, GJ; Lynn, KL; Olson, SC; Robson, RA | 1 |
| Manninen, V; Metsä-Ketelä, T; Nurmi, AK; Pörsti, I; Säynävälammi, P; Seppälä, E; Tuomisto, L; Vapaatalo, H | 1 |
| Chang, SM; Chou, TC; Ding, YA | 1 |
| Bronsoms Artero, J; Matas Serra, M; Matè Benito, G; Mauri Nicolas, JM; Torguet Escuder, P; Vallès Prats, M | 1 |
| Baudin, B; Bernard, M; Carayon, A; Ciferri, S; Fernando Ramirez-Gil, J; Lechat, P; Mougenot, N; Schaison, FH | 1 |
| Agirbasli, MA; Brown, NJ; Litchfield, WR; Vaughan, DE; Williams, GH | 1 |
| Dohi, K; Horio, T; Kangawa, K; Matsuo, H; Morimoto, A; Nagaya, N; Nishikimi, T; Yoshihara, F | 1 |
| Agirbasli, M; Brown, NJ; Vaughan, DE | 1 |
| Baigorria, ST; García, NH; Juncos, LI | 1 |
| Kawecka-Jaszcz, K; Klocek, M; Rajzer, M | 1 |
| Boomsma, F; Buikema, H; Schoemaker, RG; van Gilst, WH; van Veldhuisen, DJ; Westendorp, B | 1 |
| Arbolishvili, GN; Baklanova, NA; Belenkov, IuN; Mareev, VIu; Nasonova, SN; Skvortsov, AA; Sychev, AV | 1 |
| Buikema, H; Schoemaker, RG; van Gilst, WH; Westendorp, B | 1 |
| Baklanova, NA; Belenkov, IuN; Mareev, VIu; Masenko, VP; Nasonova, SN; Orlova, IaA; Skvortsov, AA; Sychev, AV | 1 |
| Coca, A; Ferreira-Melo, SE; Moreno, H; Nogueira, EA; Souza, LA; Ubaid-Girioli, S; Yugar-Toledo, JC | 1 |
| Coletta, E; Davies, R; Haddad, H; Leenen, FH; Ruzicka, M; White, R | 1 |
| Aleksiejczuk, M; Chabielska, E; Gromotowicz-Poplawska, A; Marcinczyk, N; Mikita, J; Stankiewicz, A; Szemraj, J | 1 |
9 trial(s) available for aldosterone and quinapril
| Article | Year |
|---|---|
Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Arrhythmias, Cardiac; Digoxin; Drug Therapy, Combination; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Hydrochlorothiazide; Isoquinolines; Male; Middle Aged; Norepinephrine; Peptidyl-Dipeptidase A; Quinapril; Randomized Controlled Trials as Topic; Renin; Single-Blind Method; Tetrahydroisoquinolines | 1990 |
Comparison of amlodipine and quinapril on ambulatory blood pressure and platelet function in hypertension.
Topics: Adult; Aged; Aldosterone; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Platelets; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Cross-Over Studies; Double-Blind Method; Female; Heart Rate; Humans; Hypertension; Isoquinolines; Male; Middle Aged; Quinapril; Renin; Tetrahydroisoquinolines; Treatment Outcome | 1995 |
Quinapril ACE-inhibition effects on adrenergic parameters in moderate essential hypertension.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Catecholamines; Electrocardiography; Female; Hemodynamics; Humans; Hypertension; Isoquinolines; Male; Middle Aged; Muscle, Smooth, Vascular; Norepinephrine; Quinapril; Renin; Renin-Angiotensin System; Sympathetic Nervous System; Tetrahydroisoquinolines | 1996 |
Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1.
Topics: Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Catecholamines; Circadian Rhythm; Creatinine; Diet, Sodium-Restricted; Fibrinolysis; Hemodynamics; Humans; Hydrocortisone; Isoquinolines; Male; Plasminogen Activator Inhibitor 1; Quinapril; Renin; Renin-Angiotensin System; Sodium; Supine Position; Tetrahydroisoquinolines; Tissue Plasminogen Activator | 1998 |
Effect of amlodipine, quinapril, and losartan on pulse wave velocity and plasma collagen markers in patients with mild-to-moderate arterial hypertension.
Topics: Adult; Aldosterone; Amlodipine; Antihypertensive Agents; Biomarkers; Blood Flow Velocity; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Collagen; Compliance; Echocardiography; Elasticity; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Pulsatile Flow; Quinapril; Severity of Illness Index; Tetrahydroisoquinolines | 2003 |
[Combined therapy with quinapril, an ACE inhibitor, and valsartan, a type 1 angiotensin II receptors blocker, for moderate chronic cardiac failure may raise the degree of neurohormonal block and improve 24-h heart rate variability compared to the effect o
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chronic Disease; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Quinapril; Renin; Tetrahydroisoquinolines; Tetrazoles; Valine; Valsartan | 2005 |
[Effects of long term therapy with angiotensin converting enzyme inhibitor quinapril, antagonist of receptors to angiotensin II valsartan, and combination of quinapril and valsartan in patients with moderate chronic heart failure. Main results of the SADK
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiac Output, Low; Chronic Disease; Drug Therapy, Combination; Exercise Tolerance; Female; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Quinapril; Tetrahydroisoquinolines; Tetrazoles; Treatment Outcome; Valine; Valsartan; Ventricular Remodeling | 2006 |
Aldosterone escape with diuretic or angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy in patients with mild to moderate hypertension.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Irbesartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines; Tetrazoles | 2007 |
Effects of ACE inhibitors on cardiac angiotensin II and aldosterone in humans: "Relevance of lipophilicity and affinity for ACE".
Topics: Adult; Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Aorta, Thoracic; Cardiac Catheterization; Coronary Sinus; Female; Humans; Hydrophobic and Hydrophilic Interactions; Hypertension; Lipids; Lisinopril; Male; Middle Aged; Perindopril; Prospective Studies; Pulmonary Wedge Pressure; Quinapril; Renin-Angiotensin System; Tetrahydroisoquinolines; Young Adult | 2010 |
9 other study(ies) available for aldosterone and quinapril
| Article | Year |
|---|---|
The pharmacokinetics and pharmacodynamics of quinapril and quinaprilat in renal impairment.
Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Female; Glomerular Filtration Rate; Heart Rate; Humans; Isoquinolines; Male; Middle Aged; Quinapril; Random Allocation; Renin; Statistics as Topic; Tetrahydroisoquinolines | 1990 |
Inhibition of angiotensin-converting enzyme with quinapril (CI-906): investigation of antihypertensive mechanisms in spontaneously hypertensive rats.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diuresis; Drinking Behavior; Isoquinolines; Kallikreins; Kininogens; Peptidyl-Dipeptidase A; Prostaglandins; Quinapril; Rats; Renin; Tetrahydroisoquinolines; Thromboxane B2; Vasopressins | 1986 |
Acute and long-term dose-response study of quinapril on hormonal profile and tissue angiotensin-converting enzyme in Wistar rats.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Aorta; Heart; Isoquinolines; Lung; Male; Myocardium; Peptidyl-Dipeptidase A; Quinapril; Rats; Rats, Wistar; Renin; Tetrahydroisoquinolines; Time Factors | 1996 |
Ventricular adrenomedullin levels correlate with the extent of cardiac hypertrophy in rats.
Topics: Adrenomedullin; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Body Weight; Calcitonin Gene-Related Peptide; Data Interpretation, Statistical; Gene Expression; Heart Ventricles; Hemodynamics; Hydralazine; Hypertrophy, Left Ventricular; Immunohistochemistry; Isoquinolines; Kidney; Male; Organ Size; Peptides; Prodrugs; Quinapril; Radioimmunoassay; Rats; Rats, Wistar; Renin; RNA, Messenger; Tetrahydroisoquinolines; Time Factors; Ventricular Pressure | 1999 |
Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Data Interpretation, Statistical; Diet, Sodium-Restricted; Female; Fibrinolysis; Heart Rate; Humans; Isoquinolines; Losartan; Male; Plasminogen Activator Inhibitor 1; Quinapril; Renin; Renin-Angiotensin System; Tetrahydroisoquinolines; Tissue Plasminogen Activator | 1999 |
Hyperkalemia, renal failure, and converting-enzyme inhibition: an overrated connection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Creatinine; Disease Models, Animal; Female; Glomerular Filtration Rate; Humans; Hyperkalemia; Hypertension, Renal; Isoquinolines; Kidney; Male; Middle Aged; Nephrectomy; Peptidyl-Dipeptidase A; Potassium; Quinapril; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Retrospective Studies; Tetrahydroisoquinolines; Uremia | 2001 |
Progressive left ventricular hypertrophy after withdrawal of long-term ACE inhibition following experimental myocardial infarction.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Endothelium, Vascular; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Quinapril; Random Allocation; Rats; Rats, Sprague-Dawley; Renin; Substance Withdrawal Syndrome; Tetrahydroisoquinolines | 2006 |
Improvement of EDHF by chronic ACE inhibition declines rapidly after withdrawal in rats with myocardial infarction.
Topics: Acetylcholine; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Factors; Endothelium, Vascular; Male; Myocardial Infarction; Quinapril; Rats; Rats, Sprague-Dawley; Tetrahydroisoquinolines; Vasodilation | 2005 |
Beneficial effect of combined spironolactone and quinapril treatment on thrombosis and hemostasis in 2K1C hypertensive rats.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antigens, Tumor-Associated, Carbohydrate; Aorta; Bleeding Time; Blood Pressure; Carboxypeptidase B2; Collagen; Drug Therapy, Combination; Hypertension; Male; Mineralocorticoid Receptor Antagonists; Plasminogen Activator Inhibitor 1; Platelet Adhesiveness; Quinapril; Rats, Wistar; Renin; Spironolactone; Tetrahydroisoquinolines; Tissue Plasminogen Activator; Venous Thrombosis | 2018 |